NXgenPort Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $1M

  • Investors
  • 11

NXgenPort General Information

Description

Developer of a digital health technology designed to maximize remote care for cancer patients. The company's technology alerts physicians to signs of infection, reduces hospitalizations and gathers important physiological data to improve patient outcomes and offers additional value for cancer researchers and drug delivery stakeholders to remotely monitor a participant's biological response to interventions, enabling health care teams to measure, monitor and report physiological body functions of patients regarding their disease and treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saint Paul, MN 55108
  • United States
+1 (651)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Saint Paul, MN 55108
  • United States
+1 (651)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NXgenPort Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Early Stage VC 24-Apr-2026 $1M In Progress Generating Revenue
11. Accelerator/Incubator 14-Mar-2025 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
9. Seed Round 18-Nov-2024 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
7. Accelerator/Incubator 04-Oct-2023 Completed Generating Revenue
6. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
5. Early Stage VC (Series A) 18-Oct-2022 Cancelled Pre-Clinical Trials
4. Grant 30-Dec-2021 $35K $180K Completed Pre-Clinical Trials
3. Accelerator/Incubator 10-Nov-2021 $180K $180K Completed Product In Beta Test
To view NXgenPort’s complete valuation and funding history, request access »

NXgenPort Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital health technology designed to maximize remote care for cancer patients. The company's technology
Other Devices and Supplies
Saint Paul, MN
4 As of 2026

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NXgenPort Competitors (1)

One of NXgenPort’s competitors is Leuko, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Leuko Venture Capital-Backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

NXgenPort Patents

NXgenPort Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026060227-A1 Systems and methods for in vivo cytometry analysis Pending 13-Sep-2024
EP-4322822-A1 Multi-spectral imaging systems for assessing health Pending 13-Apr-2021
EP-4322822-A4 Multi-spectral imaging systems for assessing health Pending 13-Apr-2021
US-20240180452-A1 Multi-spectral imaging systems for assessing health Pending 13-Apr-2021
WO-2022221419-A1 Multi-spectral imaging systems for assessing health Inactive 13-Apr-2021 A61B5/0084
To view NXgenPort’s complete patent history, request access »

NXgenPort Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NXgenPort Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Phoenix Bioscience Core Accelerator/Incubator
WBL Fellows Program Accelerator/Incubator
CANCER FUND Venture Capital Minority
Groove Capital Venture Capital Minority
Caelestinus Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

NXgenPort FAQs

  • When was NXgenPort founded?

    NXgenPort was founded in 2020.

  • Where is NXgenPort headquartered?

    NXgenPort is headquartered in Saint Paul, MN.

  • What is the size of NXgenPort?

    NXgenPort has 4 total employees.

  • What industry is NXgenPort in?

    NXgenPort’s primary industry is Other Devices and Supplies.

  • Is NXgenPort a private or public company?

    NXgenPort is a Private company.

  • What is NXgenPort’s current revenue?

    The current revenue for NXgenPort is .

  • How much funding has NXgenPort raised over time?

    NXgenPort has raised $180K.

  • Who are NXgenPort’s investors?

    Phoenix Bioscience Core, WBL Fellows Program, CANCER FUND, Groove Capital, and Caelestinus are 5 of 11 investors who have invested in NXgenPort.

  • Who are NXgenPort’s competitors?

    Leuko is a competitor of NXgenPort.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process